跳至主要内容
临床试验/NCT05090020
NCT05090020Unknown不适用

Systematic Review of Hypernatremia Following Hydatid Cyst Treatment

Trabzon Kanuni Education and Research Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
Prevention of hypernatreima

研究概览

简要总结

Hypertonic saline (HS) is one of the most widely used scolocidal agents in the treatment of hydatid cysts. Hypernatremia is one of the complications associated with the use of HS. It can cause hypernatremia, acid-base disorder, impaired lung, renal, cardiac and neurological functions and even death. Therefore, caution should be exercised in the use of HS, and open technique should be preferred in surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
7 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who developed hypernatremia (plasma sodium value above 145 mmol/L) due to HS use in the treatment of hydatid cyst were included to study -

排除标准

  • Patients who developed hypernatremia due to other treatments were excluded from the study.

结局指标

主要结局

Prevention of hypernatreima

时间窗: 3 month

Hypernatremia is plasma sodium value above 145 mmol/L.

次要结局

未报告次要终点

研究者

发起方
Trabzon Kanuni Education and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aydın Aktaş

Associate Professor Doctor

Trabzon Kanuni Education and Research Hospital

研究点 (1)

Loading locations...

相似试验